Laboratory Tests for Postoperative Hematoma Evaluation

Core Laboratory Tests

The American Society of Anesthesiologists recommends a complete blood count (CBC) as an essential test to assess for anemia from blood loss and to evaluate platelet count, which is crucial for clot formation 1, 3
Coagulation studies, including Prothrombin Time (PT)/International Normalized Ratio (INR) and Activated Partial Thromboplastin Time (aPTT), are used to evaluate the extrinsic and common coagulation pathways and the intrinsic and common coagulation pathways, respectively 1, 4
Fibrinogen level is often the first coagulation factor to reach critically low levels during major bleeding, and its measurement is important for guiding management decisions 5, 6

Platelet function testing should be considered if a patient has known or suspected platelet dysfunction, such as those on antiplatelet medications like clopidogrel 4
Viscoelastic testing, such as Thromboelastography (TEG) or Rotational Thromboelastometry (ROTEM), provides a comprehensive assessment of clot formation, strength, and breakdown, and has shorter turnaround times than traditional tests 1, 2, 3
D-dimer may be useful if there is concern for disseminated intravascular coagulation (DIC) 4

A patient's medication history is critical to identify those on anticoagulants or antiplatelet agents that may contribute to hematoma formation 7
Laboratory monitoring should be performed as soon as possible to guide management decisions, according to the American Society of Anesthesiologists 8

For patients with normal platelet function, platelet transfusion is rarely indicated if the count is >100 × 10⁹/L and usually indicated when <50 × 10⁹/L with excessive bleeding, as recommended by the American Society of Anesthesiologists 4
Fresh frozen plasma (FFP) transfusion is indicated for correction of excessive microvascular bleeding when PT is prolonged >1.5 times normal, according to the American Society of Anesthesiologists 4
For fibrinogen deficiency, the American Society of Anesthesiologists recommends considering fibrinogen concentrate or cryoprecipitate with a target fibrinogen level of at least 1.5-2.0 g/L 5, 6

The American Society of Anesthesiologists advises against relying solely on conventional coagulation tests (PT, aPTT) as they may not correlate well with clinical bleeding 5, 6
Treatment should not be delayed while waiting for laboratory results in cases of severe bleeding, as recommended by the American Society of Anesthesiologists 5, 6
Traditional tests like PT and aPTT were not designed to monitor coagulation deficiencies during hemorrhage, and their results may not reflect the dynamic clinical situation during ongoing bleeding, according to the American Society of Anesthesiologists 1, 3
Visual assessment of the surgical field remains essential and should be conducted jointly by the clinical team to determine whether excessive microvascular bleeding is occurring, as recommended by the American Society of Anesthesiologists 4, 8